Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Hui Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8617-5861; OpenAlex author ID A5000553866. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper

Papers 2

  1. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression. Co-author DOI 10.3892/ijo.2014.2500↗
  2. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. Co-author DOI 10.3892/or.2013.2529↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongfei Tong · 2 shared papers, 2013–2014 · strength 0.08
  2. Zhaohong Wang · 2 shared papers, 2013–2014 · strength 0.08
  3. Jing-Qiang Guo · 1 shared paper, 2014 · strength 0.04
  4. Liang Chen · 1 shared paper, 2014 · strength 0.04
  5. Shengzhang Lin · 1 shared paper, 2014 · strength 0.04
  6. Sheng‐Zhang Lin · 1 shared paper, 2013 · strength 0.03
  7. Heqi Bu · 1 shared paper, 2013 · strength 0.03
  8. Jianhong Zhang · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.